Recent News

Whistleblowers Deserve Gratitude Amid COVID-19 Obstacles

Today, the attorneys at Peter Angelos P.C. extend our thanks to our nation’s whistleblowers who guard the integrity of our rights and democracy, expose fraudulent practices against the government and choose right over wrong. Especially in the midst of COVID, whistleblowers and the part they play in society are paramount to exposing noncompliance and mishandling…

Read More...

Multidistrict Litigation Versus Class Action Litigation

MDL and Class Action Litigation both provide a legal mechanism for the progression and often resolution of legal issues that affect numerous individuals at the same time.   How do MDLs Differ from Class Actions?   Most lawsuits involve an injured person seeking compensation for their damages. MDLs and class action litigation include many plaintiffs/class…

Read More...

Common Spinal Cord Injuries That Car Crash Victims May Experience

Every time we start up our vehicles, we are risking our safety. Motor vehicle crashes are a leading cause of death in the U.S., according to the CDC. Yet, most Americans continue to rely on their vehicles to get around. Many car accidents can result in common yet serious injuries such as whiplash, herniated discs…

Read More...

What are Common Symptoms of Ovarian Cancer?

Ovarian cancer is a rare, yet serious, form of cancer that has been linked to brief-to-extended asbestos exposure in talcum products. It is found in the female reproductive system of cancer patients and is aggressive in nature. If you or a loved one has been exposed to asbestos-containing products, such as Johnson & Johnson’s Shower-to-Shower…

Read More...

When to Hire an Automotive Personal Injury Lawyer?

When you suffer a serious injury at the hands of a negligent party, knowing where to turn next is vital. Medical bills, pain and suffering and other financial implications can alter your daily life and ability to fully recover from your experience. The attorneys at Peter Angelos P.C. have represented victims and families in a…

Read More...

The Latest in Qui Tam: DOE Contractors Bechtel & Aecom Pay Over $57 Million to Settle Whistleblower Complaint

In recent False Claims Act news, the United States Attorney’s Office for the Eastern District of Washington announced in a press release published in late September that the Department of Energy (DOE) contractors agreed to settle whistleblower allegations by paying over $57 million. According to the press release, four relators filed a whistleblower complaint in…

Read More...

Whistleblower Uncovers Merit Medical Kickback Scheme, Leads to $18 Million Settlement

In 2016, Dr. Charles J. Wolf filed a whistleblower complaint against Merit Medical Systems upon his resignation as the company’s chief compliance officer. Wolf, who made the False Claims allegation after years of witnessing violations that were “deeply ingrained in Merit’s culture” received nearly $2.7 million of the $18 million settlement that resulted from four…

Read More...

Mercury-Containing Dental Amalgam May Have Harmful Health Effects to High-Risk Groups

On September 24th, 2020, the FDA published a press release issuing updated recommendations regarding the potential risks of mercury-containing dental amalgam fillings to high-risk groups. The FDA is issuing these updates as a response to certain risks surrounding the dental fillings that may predominantly impact certain high-risk groups.    Dental Amalgam is a Substance Used…

Read More...

FDA News Release: Opdivo and Yervoy Combination Approved to Treat Mesothelioma

For the first time in 16 years, a drug combination and FDA-approved systemic therapy has been approved to treat malignant pleural mesothelioma that cannot be removed surgically. The first-line treatment for adults will include drug combination therapy using Opdivo (nivolumab) and Yervoy (ipilimumab) to increase the chances of patient survival. Here, the pharmaceutical liability attorneys…

Read More...

Recent FDA News Release: Benzodiazepines Boxed Warning to Be Updated to Include Serious Risks

On September 23rd, the U.S. Food and Drug Administration (FDA) announced that it would be requiring “class-wide labeling changes” for psychoactive drugs that fall under the class of Benzodiazepines. The label change to the Boxed Warning will include benzos’ risks of abuse, dependence, misuse, addiction and potential withdrawal symptoms.  The labeling update is a reaction…

Read More...